Jain Anju
Department of Biochemistry, Lady Hardinge Medical College, New Delhi, 110001 India.
Indian J Clin Biochem. 2011 Jul;26(3):269-73. doi: 10.1007/s12291-010-0104-0. Epub 2011 Jan 11.
Tuberculosis remains a major public health problem globally, with India being one of the high burden countries. The common causative agent is Mycobacterium tuberculosis but in developing countries M. bovis is reported as a potential human pathogen. Almost 20% of all reported cases of tuberculosis are of extra pulmonary form of disease. Diagnosis of extra pulmonary tuberculosis (EPTB) is not always possible with conventional methods, due to the long time required and the paucibacillary nature of samples; hence the need of rapid molecular methods. A prospective study was conducted on 300 patients of EPTB over a period of 5 years. These patients were suspected cases of tubercular meningitis, tubercular ascites and tubercular lymphadenitis. Samples analyzed were cerebrospinal fluid, ascitic fluid and lymph node fine needle aspirate. A two step PCR targeting hup B gene was used. Clinical response to anti tubercular therapy (ATT) was taken as positive (gold standard). PCR for hup B gene was positive in 147 samples out of 155 ATT responders. Of these 85.71% were infected with M. tuberculosis, 9.52% with M. bovis alone and 4.76% showed co infection with both M.tb and M. bovis. The sensitivity and specificity of PCR was 90.32 and 94.48% respectively.
结核病仍然是全球主要的公共卫生问题,印度是高负担国家之一。常见病原体是结核分枝杆菌,但在发展中国家,牛分枝杆菌被报告为一种潜在的人类病原体。几乎所有报告的结核病病例中有20%为肺外疾病形式。由于所需时间长且样本中细菌数量少,传统方法并不总是能够诊断肺外结核病(EPTB);因此需要快速分子方法。在5年期间对300例EPTB患者进行了一项前瞻性研究。这些患者为结核性脑膜炎、结核性腹水和结核性淋巴结炎的疑似病例。分析的样本为脑脊液、腹水和淋巴结细针穿刺抽吸物。使用了针对hup B基因的两步PCR。将抗结核治疗(ATT)的临床反应视为阳性(金标准)。在155例ATT反应者中,有147个样本的hup B基因PCR呈阳性。其中,85.71%感染结核分枝杆菌,9.52%仅感染牛分枝杆菌,4.76%显示同时感染结核分枝杆菌和牛分枝杆菌。PCR的敏感性和特异性分别为90.32%和94.48%。